pyrroles has been researched along with Carcinoma, Papillary in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (24.14) | 29.6817 |
| 2010's | 22 (75.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Escobar, MA; McClellan, JM; Thomas, W | 1 |
| Bono, P; Joensuu, H; Peltola, K; Rautiola, J; Utriainen, T | 1 |
| Cho, IC; Chung, J; Joung, JY; Kwon, WA; Lee, KH; Nam, BH; Seo, HK; Yu, A | 1 |
| Atri, M; Bjarnason, GA; Burns, PN; Hudson, JM; Khalil, B; Kiss, A; Milot, LM; Williams, R | 1 |
| Baudin, E; Bonichon, F; Borget, I; Brassard, M; Chougnet, CN; Claude-Desroches, M; de la Fouchardière, C; Do Cao, C; Giraudet, AL; Leboulleux, S; Massicotte, MH; Schlumberger, M | 1 |
| Alonso, T; Díez, JJ; Grande, E; Iglesias, P | 1 |
| Adam, A; Barry, ER; Beran, G; Cairo, S; Clark, EA; D'Cruz, CM; Déas, O; Fawell, SE; Frigault, MM; Hattersley, M; Henry, RE; Jones, RD; Linsenmayer, D; Nicolle, D; Reimer, C; Schuller, AG; Smith, A; Wilson, J; Zinda, M | 1 |
| Altavilla, A; Boni, L; Bracarda, S; Camerini, A; Derosa, L; Di Lorenzo, G; Escudier, B; Galli, L; Iacovelli, R; Longo, F; Morelli, F; Porta, C; Procopio, G; Rizzo, M; Rossi, M; Santoni, M; Sisani, M | 1 |
| Basso, U; Maruzzo, M | 1 |
| Bracarda, S | 1 |
| Barett, C; Bikas, A; Burman, KD; Clark, BG; Desale, S; Gandhi, R; Jelinek, JS; Kundra, P; Mete, M; O'Keefe, K; Wartofsky, L; Wexler, JA; Wray, L | 1 |
| Atallah, V; Bardet, S; Bonichon, F; De La Fouchardiere, C; Dierick-Galet, A; Do Cao, C; Godbert, Y; Hocquelet, A; Italiano, A; Leboulleux, S; Leduc, N; Zerdoud, S | 1 |
| M, Eel D | 1 |
| Asselineau, J; Bournaud-Salinas, C; Caron, P; Catargi, B; Daste, A; de la Fouchardière, C; Delord, JP; Digue, L; Do Cao, C; Doussau, A; Gimbert, A; Klein, M; Nicolli-Sire, P; Pedenon, D; Picat, MQ; Pouessel, D; Ravaud, A; Rodien, P; Wemeau, JL | 1 |
| Laber, DA; Mushtaq, M | 1 |
| Choueiri, TK; Chowdhury, S | 1 |
| Moretti, S; Puxeddu, E; Romagnoli, S; Voce, P | 1 |
| Fagin, JA; Pfister, DG; Tuttle, RM | 1 |
| Fenton, MS; Hershman, JM; Hogen, R; Marion, KM; Naeim, F; Salem, AK | 1 |
| Baum, MS; Feldman, DR; Georges, M; Ginsberg, MS; Jia, X; Kroog, G; Molina, AM; Motzer, RJ; Patil, S; Reuter, VE; Tickoo, SK | 1 |
| Gkountouvas, A; Kaldrymides, P; Kostoglou-Athanassiou, I; Veniou, E; Ziras, N | 1 |
| Attias-Geva, Z; Bentov, I; Bruchim, I; Fishman, A; Werner, H | 1 |
| Ahn, SH; An, SY; Choi, IJ; Jeon, EH; Jeong, WJ; Mo, JH; Park, MW | 1 |
| Antonetti, R; Cignarelli, M; Costantino, E; Gerardi, AM; Landriscina, M; Maddalena, F; Natalicchio, MI; Piscazzi, A | 1 |
| Boni, G; Ferdeghini, M; Mariani, G; Monzani, F; Pasqualetti, G; Polini, A; Ricci, S; Tognini, S | 1 |
| Bain, J; Cazzaniga, S; Cleris, L; Formelli, F; Gambacorti-Passerini, C; Kuoni, T; Mologni, L; Puttini, M; Redaelli, S; Riva, B; Rostagno, R; Sala, E; Scapozza, L | 1 |
| Bacik, J; Ishill, N; Kondagunta, GV; Motzer, RJ; Reuter, V; Ronnen, EA; Russo, P; Spodek, L | 1 |
| Bukowski, RM; Choueiri, TK; Elson, P; Escudier, B; Negrier, S; Oudard, S; Plantade, A; Ravaud, A; Rini, BI; Zhou, M | 1 |
| Conus, NM; Dawson, SJ; Hicks, RJ; McArthur, G; Raleigh, JM; Rischin, D; Toner, GC | 1 |
3 review(s) available for pyrroles and Carcinoma, Papillary
| Article | Year |
|---|---|
Recent advances in the systemic treatment of metastatic papillary renal cancer.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Bevacizumab; Carcinoma, Papillary; Carcinoma, Renal Cell; Drug Resistance, Neoplasm; Erlotinib Hydrochloride; Humans; Indoles; Kidney Neoplasms; Neoadjuvant Therapy; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Protein Kinases; Pyridines; Pyrroles; Quinazolines; Randomized Controlled Trials as Topic; Sirolimus; Sorafenib; Sunitinib; TOR Serine-Threonine Kinases | 2009 |
Targeted molecular therapies in thyroid carcinoma.
Topics: Antineoplastic Agents; Axitinib; Benzenesulfonates; Carcinoma, Medullary; Carcinoma, Papillary; Humans; Imidazoles; Indazoles; Indoles; Niacinamide; Oligonucleotides; Phenylurea Compounds; Piperidines; Protein Kinase Inhibitors; Pyridines; Pyrroles; Quinazolines; Sorafenib; Sunitinib; Thyroid Neoplasms | 2009 |
Partial remission of metastatic papillary thyroid carcinoma with sunitinib. Report of a case and review of the literature.
Topics: Antineoplastic Agents; Carcinoma, Papillary; Combined Modality Therapy; Humans; Indoles; Male; Middle Aged; Pelvic Neoplasms; Protein Kinase Inhibitors; Pyrroles; Remission Induction; Sunitinib; Thyroid Neoplasms | 2010 |
6 trial(s) available for pyrroles and Carcinoma, Papillary
| Article | Year |
|---|---|
Pazopanib after sunitinib failure in patients with metastatic renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Carcinoma, Papillary; Carcinoma, Renal Cell; Female; Follow-Up Studies; Humans; Indazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Pyrimidines; Pyrroles; Retrospective Studies; Salvage Therapy; Sulfonamides; Sunitinib; Survival Rate; Treatment Failure | 2014 |
Outcomes in patients with metastatic renal cell cancer treated with individualized sunitinib therapy: correlation with dynamic microbubble ultrasound data and review of the literature.
Topics: Angiogenesis Inhibitors; Carcinoma, Papillary; Carcinoma, Renal Cell; Female; Follow-Up Studies; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Pyrroles; Retrospective Studies; Review Literature as Topic; Sunitinib; Survival Rate | 2014 |
Phase 2 clinical trial of sunitinib as adjunctive treatment in patients with advanced differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Carcinoma; Carcinoma, Papillary; Chemotherapy, Adjuvant; Diarrhea; Disease-Free Survival; Fatigue; Female; Hand-Foot Syndrome; Humans; Indoles; Iodine Radioisotopes; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Pyrroles; Radiotherapy; Sunitinib; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2016 |
A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Angiogenesis Inhibitors; Bone Neoplasms; Carcinoma; Carcinoma, Neuroendocrine; Carcinoma, Papillary; Female; Humans; Indoles; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Pyrroles; Sunitinib; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Treatment Outcome | 2017 |
Compassionate use of sorafenib in patients with advanced renal cell cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Papillary; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Sunitinib; Treatment Outcome | 2009 |
Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Papillary; Carcinoma, Renal Cell; Disease-Free Survival; Drug Administration Schedule; Early Termination of Clinical Trials; Female; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; New York City; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Survival Analysis; Time Factors; Treatment Outcome; Young Adult | 2012 |
20 other study(ies) available for pyrroles and Carcinoma, Papillary
| Article | Year |
|---|---|
Solid pseudopapillary tumour (Frantz's tumour) of the pancreas in childhood: successful management of late liver metastases with sunitinib and chemoembolisation.
Topics: Adolescent; Antineoplastic Agents; Carcinoma, Papillary; Combined Modality Therapy; Embolization, Therapeutic; Female; Humans; Indoles; Liver Neoplasms; Magnetic Resonance Imaging; Pancreas; Pancreatic Neoplasms; Pancreaticoduodenectomy; Pyrroles; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Validation of the MSKCC and Heng risk criteria models for predicting survival in patients with metastatic renal cell carcinoma treated with sunitinib.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Papillary; Carcinoma, Renal Cell; Female; Follow-Up Studies; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Nomograms; Prognosis; Pyrroles; Retrospective Studies; Risk Factors; Sunitinib; Survival Rate | 2013 |
Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network.
Topics: Adenocarcinoma; Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Carcinoma; Carcinoma, Neuroendocrine; Carcinoma, Papillary; Disease-Free Survival; Female; Humans; Indoles; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Piperidines; Pleural Neoplasms; Protein-Tyrosine Kinases; Pyrroles; Quinazolines; Retrospective Studies; Sorafenib; Sunitinib; Thyroid Cancer, Papillary; Thyroid Neoplasms; Treatment Outcome | 2014 |
Activity and safety of sunitinib in patients with advanced radioactive iodine-refractory differentiated thyroid carcinoma in clinical practice.
Topics: Adenocarcinoma, Follicular; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma; Carcinoma, Papillary; Disease Progression; Female; Humans; Indoles; Male; Middle Aged; Pyrroles; Retrospective Studies; Sunitinib; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Treatment Outcome | 2015 |
The MET Inhibitor AZD6094 (Savolitinib, HMPL-504) Induces Regression in Papillary Renal Cell Carcinoma Patient-Derived Xenograft Models.
Topics: Animals; Antineoplastic Agents; Carcinoma, Papillary; Carcinoma, Renal Cell; Cell Line, Tumor; Crizotinib; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Indoles; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Pyrazines; Pyrazoles; Pyridines; Pyrroles; Sunitinib; Triazines; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Papillary; Carcinoma, Renal Cell; Female; Follow-Up Studies; Humans; Indoles; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Pyrroles; Retrospective Studies; Sunitinib; Survival Rate | 2015 |
More on sunitinib 2 weeks on/1 week off schedule: the Rainbow analysis.
Topics: Bone Neoplasms; Carcinoma, Papillary; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Pyrroles | 2016 |
More colors to the palette.
Topics: Bone Neoplasms; Carcinoma, Papillary; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Pyrroles | 2016 |
Activity and Safety of Sunitinib in Patients with Advanced Radioiodine Refractory Thyroid Carcinoma: A Retrospective Analysis of 57 Patients.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Papillary; Disease-Free Survival; Female; Humans; Indoles; Male; Middle Aged; Pyrroles; Retrospective Studies; Sunitinib; Survival Rate; Thyroid Neoplasms; Treatment Outcome | 2016 |
Utilization of Sunitinib for Renal Cell Cancer: an Egyptian University hospital experience.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Papillary; Carcinoma, Renal Cell; Egypt; Female; Follow-Up Studies; Hospitals, University; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Pyrroles; Sunitinib; Survival Rate; Young Adult | 2016 |
Harvesting the low-hanging fruit: kinase inhibitors for therapy of advanced medullary and nonmedullary thyroid cancer.
Topics: Adenocarcinoma, Follicular; Antineoplastic Agents; Benzenesulfonates; Biomarkers, Tumor; Carcinoma, Medullary; Carcinoma, Papillary; Humans; Indoles; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Sorafenib; Sunitinib; Thyroid Neoplasms | 2010 |
Sunitinib inhibits MEK/ERK and SAPK/JNK pathways and increases sodium/iodide symporter expression in papillary thyroid cancer.
Topics: Antineoplastic Agents; Carcinoma, Papillary; Cell Line, Tumor; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Humans; Indoles; MAP Kinase Kinase 4; Protein Kinase Inhibitors; Pyrroles; Signal Transduction; Sunitinib; Symporters; Thyroid Neoplasms | 2010 |
Insulin-like growth factor-I receptor inhibition by specific tyrosine kinase inhibitor NVP-AEW541 in endometrioid and serous papillary endometrial cancer cell lines.
Topics: Apoptosis; Carcinoma, Endometrioid; Carcinoma, Papillary; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Humans; Molecular Targeted Therapy; Phosphorylation; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Receptor, Insulin; Signal Transduction | 2011 |
Sunitinib inhibits papillary thyroid carcinoma with RET/PTC rearrangement but not BRAF mutation.
Topics: Animals; Carcinoma; Carcinoma, Papillary; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA-Binding Proteins; Extracellular Signal-Regulated MAP Kinases; Humans; Indoles; MAP Kinase Kinase Kinases; Mice; Mutation; Nuclear Proteins; Proto-Oncogene Proteins B-raf; Pyrroles; raf Kinases; Signal Transduction; Sunitinib; Thyroid Cancer, Papillary; Thyroid Neoplasms; Xenograft Model Antitumor Assays | 2011 |
Activation of the RAS/RAF/ERK signaling pathway contributes to resistance to sunitinib in thyroid carcinoma cell lines.
Topics: Adenocarcinoma, Follicular; Antineoplastic Agents; Carcinoma, Papillary; Cell Line, Tumor; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; Humans; Indoles; MAP Kinase Signaling System; Oncogene Proteins, Fusion; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Pyrroles; ras Proteins; Sunitinib; Thyroid Neoplasms | 2012 |
Off-label use of sunitinib in patients with advanced, epithelial thyroid cancer: a retrospective analysis.
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Aged; Antineoplastic Agents; Carcinoma; Carcinoma, Papillary; Disease-Free Survival; Female; Humans; Indoles; Male; Middle Aged; Neoplasm Metastasis; Off-Label Use; Protein-Tyrosine Kinases; Pyrroles; Retrospective Studies; Sunitinib; Thyroid Cancer, Papillary; Thyroid Neoplasms; Treatment Outcome | 2012 |
Inhibition of RET tyrosine kinase by SU5416.
Topics: Animals; Carcinoma, Papillary; Female; Humans; Indoles; Insecta; Mice; Mice, Nude; Models, Biological; Models, Molecular; Mutant Proteins; NIH 3T3 Cells; Phosphorylation; Protein Kinase Inhibitors; Protein Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Pyrroles; Sensitivity and Specificity; Thyroid Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2006 |
Treatment outcome for metastatic papillary renal cell carcinoma patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Carcinoma, Renal Cell; Clinical Trials as Topic; Cytokines; Female; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Retrospective Studies; Sunitinib; Survival Rate; Treatment Outcome | 2006 |
Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Papillary; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Prognosis; Pyridines; Pyrroles; Sorafenib; Sunitinib; Survival Rate; Treatment Outcome | 2008 |
Sustained clinical responses to tyrosine kinase inhibitor sunitinib in thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Aged; Antineoplastic Agents; Blotting, Western; Carcinoma, Papillary; Humans; Immunohistochemistry; Indoles; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Protein-Tyrosine Kinases; Pyrroles; Sunitinib; Thyroid Neoplasms | 2008 |